Cargando…
Baseline and time‐updated factors in preclinical development of anionic dendrimers as successful anti‐HIV‐1 vaginal microbicides
Although a wide variety of topical microbicides provide promising in vitro and in vivo efficacy, most of them failed to prevent sexual transmission of human immunodeficiency virus type 1 (HIV‐1) in human clinical trials. In vitro, ex vivo, and in vivo models must be optimized, considering the knowle...
Autores principales: | Rodríguez‐Izquierdo, Ignacio, Sepúlveda‐Crespo, Daniel, Lasso, Jose María, Resino, Salvador, Muñoz‐Fernández, Ma Ángeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285063/ https://www.ncbi.nlm.nih.gov/pubmed/35018739 http://dx.doi.org/10.1002/wnan.1774 |
Ejemplares similares
-
G2-S16 dendrimer microbicide does not interfere with the vaginal immune system
por: Martín-Moreno, Alba, et al.
Publicado: (2019) -
Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants
por: Rodríguez-Izquierdo, I., et al.
Publicado: (2022) -
Safety of G2-S16 Polyanionic Carbosilane Dendrimer as Possible HIV-1 Vaginal Microbicide
por: Martin-Moreno, Alba, et al.
Publicado: (2022) -
Stress and Depression: Preclinical Research and Clinical Implications
por: Bartolomucci, Alessandro, et al.
Publicado: (2009) -
G1-S4 or G2-S16 carbosilane dendrimer in combination with Platycodin D as a promising vaginal microbicide candidate with contraceptive activity
por: Ceña-Diez, Rafael, et al.
Publicado: (2019)